|
| 36302640 | Relationship between intrinsic network connectivity and psychiatric symptom severity in functional seizures. | J Neurol Neurosurg Psychiatry | 2023 |
| 38025406 | Do people with epilepsy want to participate in an exercise intervention randomized controlled trial? - Results of a brief survey and its preliminary application. | Epilepsy Behav Rep | 2023 |
| 37917918 | Functional Magnetic Resonance Imaging Activation During Unscripted Discourse in People With Poststroke Aphasia. | J Speech Lang Hear Res | 2023 |
| 38077237 | Peripheral and Central Nervous System Biomarkers of Inflammation in Functional Seizures: Assessment with Magnetic Resonance Spectroscopy. | Neuropsychiatr Dis Treat | 2023 |
| 37593907 | Final analysis of potential drug-drug interactions between highly purified cannabidiol and anti-seizure medications in an open-label expanded access program. | Epilepsia Open | 2023 |
| 37517050 | Later onset focal epilepsy with roots in childhood: Evidence from early learning difficulty and brain volumes in the Human Epilepsy Project. | Epilepsia | 2023 |
| 37549503 | Improvements in Montreal Cognitive Assessment scores after neurobehavioral therapy in adults with functional (nonepileptic) seizures and traumatic brain injury. | J Psychiatr Res | 2023 |
| 37684497 | Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records. | CNS Drugs | 2023 |
| 37813409 | An exploratory study of brain temperature and choline abnormalities in temporal lobe epilepsy patients with depressive symptoms. | Epilepsia Open | 2023 |
| 37084040 | White Matter Changes after Neurobehavioral Therapy for Functional Seizures. | Ann Neurol | 2023 |
| 37413772 | White matter microstructure and serum biomarkers of inflammation in psychogenic non-epileptic seizures. | Neuroimage Clin | 2023 |
| 37210714 | Repeatability of neurite orientation dispersion and density imaging in patients with traumatic brain injury. | J Neuroimaging | 2023 |
| 37243404 | Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program. | Epilepsia | 2023 |
| 36872138 | Sense of control, selective attention, cognitive inhibition, and psychosocial outcomes after Retraining and Control Therapy (ReACT) in pediatric functional seizures. | Epilepsy Behav | 2023 |
| 36539302 | Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy: An Analysis of a Complex Comorbidity. | Neurology | 2023 |
| 36537757 | Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program. | Epilepsia | 2023 |
| 36762949 | Concordance between focal brain temperature elevations and focal edema in temporal lobe epilepsy. | Epilepsia | 2023 |
| 36410152 | Psychosocial outcomes of repeated treatment of seizure clusters with midazolam nasal spray: Results of a phase 3, open-label extension trial. | Epilepsy Behav | 2023 |
| 34730239 | Regional brain atrophy and aberrant cortical folding relate to anxiety and depression in patients with traumatic brain injury and psychogenic nonepileptic seizures. | Epilepsia | 2022 |
| 35444505 | Not a Slam-Dunk: Assessing the Role of EEG/fMRI in the Presurgical Evaluation. | Epilepsy Curr | 2022 |
| 35410903 | Prediction of Naming Outcome With fMRI Language Lateralization in Left Temporal Epilepsy Surgery. | Neurology | 2022 |
| 35430472 | Sense of control, selective attention and cognitive inhibition in pediatric functional seizures: A prospective case-control study. | Seizure | 2022 |
| 35462300 | Psychiatric and personality factors in pediatric functional seizures: A prospective case-control study. | Seizure | 2022 |
| 35422175 | Precision rehabilitation for aphasia by patient age, sex, aphasia severity, and time since stroke? A prespecified, systematic review-based, individual participant data, network, subgroup meta-analysis. | Int J Stroke | 2022 |
| 35526462 | Diagnostic delay in functional seizures is associated with abnormal processing of facial emotions. | Epilepsy Behav | 2022 |
| 36467455 | Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: A systematic review and individual participant data meta-analysis. | EClinicalMedicine | 2022 |
| 35132632 | Visually sensitive seizures: An updated review by the Epilepsy Foundation. | Epilepsia | 2022 |
| 35243477 | Lesion correlates of auditory sentence comprehension deficits in post-stroke aphasia. | Neuroimage Rep | 2022 |
| 35112346 | Precentral gyrus and insula responses to stress vary with duration to diagnosis in functional seizures. | Epilepsia | 2022 |
| 35198954 | Special issue on the intersection between functional seizures and other functional neurological disorders. | Epilepsy Behav Rep | 2022 |
| 32412102 | Shared lesion correlates of semantic and letter fluency in post-stroke aphasia. | J Neuropsychol | 2021 |
| 33770613 | Relationships between cognitive function, seizure control, and self-reported leisure-time exercise in epilepsy. | Epilepsy Behav | 2021 |
| 33493803 | Coffee and cigarette smoking interactions with lamotrigine. | Epilepsy Behav | 2021 |
| 33642971 | Clear and Consistent Imaging of Hippocampal Internal Architecture With High Resolution Multiple Image Co-registration and Averaging (HR-MICRA). | Front Neurosci | 2021 |
| 33667843 | Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy. | Epilepsy Behav | 2021 |
| 33725662 | White matter integrity after cannabidiol administration for treatment resistant epilepsy. | Epilepsy Res | 2021 |
| 33663247 | Thalamus and Seizures-Here We Come Again⿦. | Epilepsy Curr | 2021 |
| 34917920 | Neuroinflammation as a pathophysiological factor in the development and maintenance of functional seizures: A hypothesis. | Epilepsy Behav Rep | 2021 |
| 35243288 | Neurology residents' education in functional seizures. | Epilepsy Behav Rep | 2021 |
| 34877515 | The role of evidence-based guidelines in the diagnosis and treatment of functional neurological disorder. | Epilepsy Behav Rep | 2021 |
| 34924824 | A "Sodium Drug" for Generalized Epilepsy? A Mystery That Still Needs to be Solved. | Epilepsy Curr | 2021 |
| 34862359 | A Pilot Randomized Controlled Trial of Intermittent Theta Burst Stimulation as Stand-Alone Treatment for Post-Stroke Aphasia: Effects on Language and Verbal Functional Magnetic Resonance Imaging (fMRI). | Med Sci Monit | 2021 |
| 34521687 | Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 Study. | Neurology | 2021 |
| 34521043 | A systematic review of seizure clusters: Prevalence, risk factors, burden of disease and treatment patterns. | Epilepsy Res | 2021 |
| 34464454 | Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant Epilepsy. | Clin Pharmacol Ther | 2021 |
| 34690561 | The Molecular Dichotomy Between Epileptic and Functional Seizures. | Epilepsy Curr | 2021 |
| 34600280 | A feasibility study to assess social stress and social support in patients enrolled in a cannabidiol (CBD) compassionate access program. | Epilepsy Behav | 2021 |
| 34568805 | Identifying and evaluating novel treatment targets for the development of evidence-based interventions for functional neurological disorder. | Epilepsy Behav Rep | 2021 |
| 34563808 | Cannabidiol (CBD) and cognition in epilepsy. | Epilepsy Behav | 2021 |
| 34619526 | Retraining and Control Therapy (ReACT) is a bottom-up, body-oriented intervention. | Seizure | 2021 |